AM

Alex Martin

Chief Executive Officer

Abcuro, Inc

Philadelphia, Pennsylvania


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Abcuro, Inc
Industry
research
Employees
49.0
Seniority
C suite
Annual Revenue
2700000.0
Total Funding
407250000.0
Latest Funding
Series C

Technologies

Outlook GoDaddy Hosting WordPress.org Google Font API Apache Mobile Friendly Data Analytics Basis Remote AI

Keywords

biotechnology research autoimmune diseases cancer therapies clinical trials cytotoxic t cells klrg1 monoclonal antibody abc008 t-lgll inclusion body myositis immunotherapy nk cells selective targeting immune modulation phase 1 clinical trials phase 2 clinical trials disease indications therapeutic antibodies research & development biopharmaceuticals first-in-class therapies drug development regulatory approval patient safety immuno-oncology effector t cells chronic tissue damage cytokine production immune checkpoint signaling pathways treatment efficacy treatment safety rare cancers therapeutic approaches biotechnology precision medicine chronic inflammatory conditions adaptive immunity tumor microenvironment cancer immunotherapy patient enrollment pharmacokinetics pharmacodynamics data safety monitoring therapeutic development clinical research biomarkers sparing t cells targeted therapies chronic diseases therapeutic interventions health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans